Jason Bednar
Stock Analyst at Piper Sandler
(2.36)
# 2,493
Out of 4,876 analysts
173
Total ratings
43.07%
Success rate
-1.8%
Average return
Main Sectors:
Stocks Rated by Jason Bednar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVCR NovoCure | Reiterates: Overweight | $34 | $17.42 | +95.18% | 11 | Jun 27, 2025 | |
| COO The Cooper Companies | Reiterates: Overweight | $115 → $105 | $71.70 | +46.44% | 13 | May 30, 2025 | |
| MMSI Merit Medical Systems | Maintains: Overweight | $106 → $110 | $93.60 | +17.52% | 12 | May 23, 2025 | |
| SOLV Solventum | Upgrades: Overweight | $78 → $87 | $75.44 | +15.32% | 6 | May 19, 2025 | |
| KRMD KORU Medical Systems | Maintains: Neutral | $4.5 → $3.5 | $3.56 | -1.69% | 7 | May 8, 2025 | |
| MASI Masimo | Reiterates: Overweight | $215 → $200 | $167.57 | +19.35% | 15 | May 7, 2025 | |
| BDX Becton, Dickinson and Company | Downgrades: Neutral | $260 → $185 | $172.03 | +7.54% | 9 | May 2, 2025 | |
| LUNG Pulmonx | Reiterates: Overweight | $10 → $9 | $2.65 | +239.62% | 11 | May 1, 2025 | |
| ALGN Align Technology | Reiterates: Overweight | $235 → $250 | $188.63 | +32.53% | 30 | May 1, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $20 → $16 | $15.93 | +0.47% | 8 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $83 → $77 | $73.63 | +4.58% | 7 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $18 → $17 | $19.72 | -13.79% | 12 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $13 | $11.43 | +13.74% | 2 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $5 → $4.5 | $1.63 | +176.07% | 3 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $260 → $265 | $240.08 | +10.38% | 9 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $8 → $6 | $2.15 | +179.72% | 5 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $7 | $3.05 | +129.51% | 5 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $3.5 → $1 | $0.17 | +491.72% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $310 → $372 | $543.45 | -31.55% | 4 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $95 | $74.98 | +26.70% | 1 | Apr 19, 2023 |
NovoCure
Jun 27, 2025
Reiterates: Overweight
Price Target: $34
Current: $17.42
Upside: +95.18%
The Cooper Companies
May 30, 2025
Reiterates: Overweight
Price Target: $115 → $105
Current: $71.70
Upside: +46.44%
Merit Medical Systems
May 23, 2025
Maintains: Overweight
Price Target: $106 → $110
Current: $93.60
Upside: +17.52%
Solventum
May 19, 2025
Upgrades: Overweight
Price Target: $78 → $87
Current: $75.44
Upside: +15.32%
KORU Medical Systems
May 8, 2025
Maintains: Neutral
Price Target: $4.5 → $3.5
Current: $3.56
Upside: -1.69%
Masimo
May 7, 2025
Reiterates: Overweight
Price Target: $215 → $200
Current: $167.57
Upside: +19.35%
Becton, Dickinson and Company
May 2, 2025
Downgrades: Neutral
Price Target: $260 → $185
Current: $172.03
Upside: +7.54%
Pulmonx
May 1, 2025
Reiterates: Overweight
Price Target: $10 → $9
Current: $2.65
Upside: +239.62%
Align Technology
May 1, 2025
Reiterates: Overweight
Price Target: $235 → $250
Current: $188.63
Upside: +32.53%
DENTSPLY SIRONA
Apr 30, 2025
Maintains: Neutral
Price Target: $20 → $16
Current: $15.93
Upside: +0.47%
Apr 30, 2025
Maintains: Overweight
Price Target: $83 → $77
Current: $73.63
Upside: +4.58%
Apr 30, 2025
Maintains: Neutral
Price Target: $18 → $17
Current: $19.72
Upside: -13.79%
Apr 23, 2025
Maintains: Neutral
Price Target: $15 → $13
Current: $11.43
Upside: +13.74%
Mar 28, 2025
Maintains: Overweight
Price Target: $5 → $4.5
Current: $1.63
Upside: +176.07%
Feb 3, 2025
Maintains: Overweight
Price Target: $260 → $265
Current: $240.08
Upside: +10.38%
Nov 7, 2024
Maintains: Overweight
Price Target: $8 → $6
Current: $2.15
Upside: +179.72%
Aug 15, 2024
Reiterates: Overweight
Price Target: $7
Current: $3.05
Upside: +129.51%
Aug 7, 2024
Maintains: Overweight
Price Target: $3.5 → $1
Current: $0.17
Upside: +491.72%
Jan 3, 2024
Maintains: Outperform
Price Target: $310 → $372
Current: $543.45
Upside: -31.55%
Apr 19, 2023
Initiates: Overweight
Price Target: $95
Current: $74.98
Upside: +26.70%